See more : Deliveroo plc (ROO.L) Income Statement Analysis – Financial Results
Complete financial analysis of EDAP TMS S.A. (EDAP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EDAP TMS S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- Amerco Series N Non-Voting Common Stock When-Issued (UHALV) Income Statement Analysis – Financial Results
- Zurn Elkay Water Solutions Corporation (ZWS) Income Statement Analysis – Financial Results
- AirSculpt Technologies, Inc. (AIRS) Income Statement Analysis – Financial Results
- Radico Khaitan Limited (RADICO.NS) Income Statement Analysis – Financial Results
- Delta Apparel, Inc. (DLA) Income Statement Analysis – Financial Results
EDAP TMS S.A. (EDAP)
About EDAP TMS S.A.
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.42M | 55.11M | 44.07M | 41.66M | 44.91M | 39.18M | 35.75M | 35.61M | 32.25M | 26.79M | 24.08M | 26.07M | 22.29M | 23.71M | 24.89M | 23.05M | 22.36M | 20.27M | 20.79M | 22.15M | 18.44M | 19.98M | 24.01M | 27.33M | 19.16M | 23.19M | 32.73M |
| Cost of Revenue | 36.01M | 30.92M | 25.64M | 23.28M | 23.91M | 22.27M | 20.94M | 19.20M | 18.47M | 15.58M | 14.76M | 15.63M | 13.44M | 14.25M | 14.21M | 13.96M | 13.17M | 11.95M | 12.30M | 13.67M | 13.07M | 11.51M | 15.22M | 14.23M | 10.77M | 11.60M | 16.18M |
| Gross Profit | 24.41M | 24.19M | 18.42M | 18.38M | 21.00M | 16.92M | 14.81M | 16.41M | 13.79M | 11.20M | 9.32M | 10.43M | 8.86M | 9.46M | 10.67M | 9.10M | 9.19M | 8.32M | 8.49M | 8.48M | 5.37M | 8.47M | 8.79M | 13.10M | 8.39M | 11.60M | 16.55M |
| Gross Profit Ratio | 40.40% | 43.90% | 41.81% | 44.11% | 46.76% | 43.17% | 41.43% | 46.08% | 42.74% | 41.82% | 38.70% | 40.03% | 39.73% | 39.88% | 42.89% | 39.47% | 41.11% | 41.05% | 40.83% | 38.29% | 29.12% | 42.37% | 36.62% | 47.92% | 43.77% | 50.00% | 50.56% |
| Research & Development | 6.96M | 4.92M | 3.40M | 4.50M | 3.73M | 4.09M | 3.88M | 3.87M | 2.69M | 2.93M | 2.60M | 2.66M | 2.44M | 3.27M | 3.65M | 4.26M | 3.20M | 2.44M | 1.78M | 1.52M | 3.06M | 3.19M | 3.44M | 3.98M | 3.14M | 3.24M | 3.36M |
| General & Administrative | 14.63M | 7.15M | 5.90M | 4.34M | 4.22M | 3.59M | 3.43M | 3.30M | 3.20M | 3.33M | 3.20M | 3.19M | 3.04M | 3.32M | 3.82M | 3.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 22.63M | 16.38M | 10.73M | 9.28M | 10.85M | 10.55M | 9.53M | 8.86M | 7.41M | 6.68M | 6.28M | 6.62M | 5.87M | 6.68M | 6.40M | 5.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 37.26M | 23.53M | 16.63M | 13.61M | 15.07M | 14.14M | 12.95M | 12.15M | 10.61M | 10.01M | 9.48M | 9.81M | 8.92M | 10.01M | 10.22M | 9.55M | 9.87M | 8.70M | 8.03M | 7.47M | 10.44M | 9.92M | 9.59M | 11.51M | 11.57M | 12.96M | 12.55M |
| Other Expenses | 1.00K | 0.00 | 0.00 | -1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 174.57K | 0.00 | 0.00 | -282.00K | 0.00 | 0.00 | 0.00 | 0.00 | 224.28K | 267.46K | 0.00 | 317.20K | -23.03K | 136.27K | 92.16K | 1.35M | 1.80M | 1.53M | 1.45M |
| Operating Expenses | 44.22M | 28.45M | 20.04M | 18.11M | 18.80M | 18.23M | 16.84M | 16.02M | 13.30M | 12.94M | 12.07M | 12.46M | 11.35M | 13.27M | 13.87M | 13.80M | 13.29M | 11.41M | 9.81M | 9.31M | 13.48M | 13.25M | 13.12M | 16.84M | 16.51M | 17.74M | 17.36M |
| Cost & Expenses | 80.24M | 59.37M | 45.68M | 41.39M | 42.71M | 40.50M | 37.77M | 35.22M | 31.77M | 28.52M | 26.84M | 28.10M | 24.79M | 27.53M | 28.09M | 27.76M | 26.46M | 23.36M | 22.12M | 22.98M | 26.55M | 24.76M | 28.33M | 31.07M | 27.28M | 29.33M | 33.55M |
| Interest Income | 1.31M | 404.00K | 10.00K | 10.00K | 20.00K | 19.00K | 18.00K | 21.00K | 18.00K | 31.00K | 59.00K | 126.00K | 185.00K | 265.00K | 252.00K | 412.00K | 331.28K | 224.28K | 186.59K | 146.06K | 177.07K | 455.52K | 992.41K | 0.00 | 0.00 | 511.60K | 0.00 |
| Interest Expense | 232.00K | 168.00K | 52.00K | 108.00K | 165.00K | 111.00K | 44.00K | 57.00K | 64.00K | 65.00K | 1.97M | 2.07M | 875.00K | 2.14M | 1.45M | 1.41M | 378.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.91M | 1.61M | 2.00M | 2.06M | 2.07M | 1.52M | 1.48M | 1.07M | 1.00M | 900.00K | 1.18M | 931.00K | 1.41M | 1.23M | 1.80M | 1.79M | 1.30M | 1.26M | 1.20M | 1.05M | 981.42K | 1.12M | 1.10M | 1.35M | 1.80M | 1.53M | 1.45M |
| EBITDA | -18.39M | -323.00K | 309.00K | 2.37M | 2.06M | 295.00K | 1.32M | 1.38M | 1.45M | 569.00K | -1.74M | -1.15M | -2.93M | -8.41M | -4.44M | 4.85M | -3.90M | -1.13M | -119.89K | 614.49K | -7.13M | -3.66M | -3.22M | -2.40M | -6.32M | -4.60M | 636.36K |
| EBITDA Ratio | -30.43% | -11.22% | -9.02% | 3.91% | 4.60% | -4.73% | -3.13% | 0.81% | -0.66% | -4.88% | -6.33% | -13.57% | -13.14% | -19.83% | -4.63% | -10.95% | -5.43% | -5.60% | -1.67% | 2.77% | -34.83% | -21.76% | -62.67% | -77.40% | -42.65% | -14.71% | -1.11% |
| Operating Income | -19.81M | -4.26M | -1.61M | -477.00K | 185.00K | -1.32M | -2.03M | 392.00K | 488.00K | -1.74M | -2.76M | -2.03M | -2.50M | 3.82M | 3.20M | 4.70M | 4.10M | 3.09M | 1.32M | 829.15K | 8.11M | 4.78M | 5.12M | 3.75M | -8.12M | 6.14M | -818.18K |
| Operating Income Ratio | -32.79% | -7.72% | -3.66% | -1.14% | 0.41% | -3.36% | -5.67% | 1.10% | 1.51% | -6.48% | -11.44% | -7.79% | -11.20% | 16.10% | 12.87% | 20.40% | 18.31% | 15.27% | 6.36% | 3.74% | 43.96% | 23.93% | 21.34% | 13.71% | -42.36% | 26.47% | -2.50% |
| Total Other Income/Expenses | -720.00K | 2.16M | 2.51M | -711.00K | 2.01M | 1.34M | 1.73M | 4.05M | -1.40M | 1.34M | -2.13M | -5.33M | 1.95M | -7.96M | -10.90M | -3.06M | -9.67M | -6.47M | -2.28M | -1.70M | -17.18M | -8.66M | 2.91M | 8.32M | 1.61M | -13.22M | 909.09K |
| Income Before Tax | -20.53M | -2.10M | 893.00K | -1.19M | 2.19M | 20.00K | -294.00K | 4.44M | -907.00K | -396.00K | -4.89M | -7.36M | -543.00K | -11.78M | -7.69M | 1.11M | -5.58M | -3.37M | -959.98K | -870.46K | -9.07M | -3.88M | 8.03M | 12.07M | -6.51M | -7.08M | 90.91K |
| Income Before Tax Ratio | -33.98% | -3.80% | 2.03% | -2.85% | 4.88% | 0.05% | -0.82% | 12.48% | -2.81% | -1.48% | -20.29% | -28.23% | -2.44% | -49.68% | -30.92% | 4.79% | -24.95% | -16.65% | -4.62% | -3.93% | -49.21% | -19.40% | 33.46% | 44.15% | -33.95% | -30.51% | 0.28% |
| Income Tax Expense | 644.00K | 837.00K | 193.00K | 516.00K | 679.00K | 358.00K | 388.00K | 602.00K | 759.00K | 116.00K | 135.00K | 118.00K | 395.00K | 939.00K | 72.00K | -492.00K | -139.92K | 56.07K | 103.85K | 278.11K | -113.55K | 166.77K | 883.39K | 323.68K | -256.40K | 85.27K | -90.91K |
| Net Income | -21.18M | -2.93M | 700.00K | -1.70M | 1.51M | -338.00K | -681.00K | 3.84M | -1.67M | -512.00K | -5.02M | -7.48M | -938.00K | -12.72M | -7.77M | 1.60M | -5.44M | -3.43M | -1.06M | -1.15M | -8.96M | -4.04M | 7.15M | 11.74M | -6.25M | -7.16M | 181.82K |
| Net Income Ratio | -35.05% | -5.32% | 1.59% | -4.09% | 3.37% | -0.86% | -1.91% | 10.79% | -5.17% | -1.91% | -20.85% | -28.68% | -4.21% | -53.64% | -31.21% | 6.93% | -24.32% | -16.93% | -5.12% | -5.18% | -48.59% | -20.24% | 29.78% | 42.97% | -32.61% | -30.88% | 0.56% |
| EPS | -0.57 | -0.09 | 0.02 | -0.06 | 0.05 | -0.01 | -0.02 | 0.14 | -0.07 | -0.02 | -0.24 | -0.43 | -0.07 | -0.98 | -0.74 | 0.17 | -0.59 | -0.39 | -0.14 | -0.15 | -1.15 | -0.52 | 0.92 | 1.50 | -0.80 | -0.86 | 0.03 |
| EPS Diluted | -0.57 | -0.09 | 0.02 | -0.06 | 0.05 | -0.01 | -0.02 | 0.13 | -0.07 | -0.02 | -0.24 | -0.43 | -0.07 | -0.97 | -0.73 | 0.17 | -0.59 | -0.36 | -0.13 | -0.14 | -1.15 | -0.52 | 0.90 | 1.42 | -0.80 | -0.86 | 0.03 |
| Weighted Avg Shares Out | 37.00M | 34.39M | 32.13M | 29.15M | 29.02M | 29.00M | 28.96M | 27.82M | 23.81M | 23.60M | 20.59M | 17.38M | 13.35M | 13.01M | 10.51M | 9.58M | 9.20M | 8.82M | 7.78M | 7.78M | 7.78M | 7.77M | 7.76M | 7.78M | 7.80M | 8.32M | 6.67M |
| Weighted Avg Shares Out (Dil) | 37.00M | 34.39M | 32.42M | 29.15M | 29.62M | 29.00M | 28.96M | 29.37M | 25.02M | 23.60M | 20.59M | 17.56M | 13.35M | 13.09M | 10.57M | 9.66M | 9.20M | 9.56M | 8.37M | 8.07M | 7.82M | 7.83M | 7.94M | 8.27M | 7.80M | 8.32M | 6.67M |
EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update
EDAP TMS S.A. (EDAP) Stock Jumps 18.8%: Will It Continue to Soar?
A Preview Of Edap TMS's Earnings
EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery
EDAP TMS (EDAP) Surges: Stock Moves 6% Higher
EDAP Announces End of the Year Focal One® Sales
Source: https://incomestatements.info
Category: Stock Reports